The cell line is not validated yet.
SYSUTFi001-A
General
Cell Line |
|
| hPSCreg name | SYSUTFi001-A |
| Cite as: | SYSUTFi001-A (RRID:CVCL_C1XG) |
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
UKAi002-A (PBMNC2_hiPS_007, PV1 JAK2) Donor's gene variants: JAK2, JAK2 Donor diseases: Polycythemia Vera UKAi002-B (PBMNC2_hiPS_009, PV1 JAK2 V617F het) Donor's gene variants: JAK2, JAK2 Donor diseases: Polycythemia Vera |
| Last update | 8th November 2022 |
| User feedback | |
Provider |
|
| Generator | The First Affiliated Hospital (SYSUTF) |
External Databases |
|
| BioSamples | SAMEA14300243 |
| Cellosaurus | CVCL_C1XG |
| Wikidata | Q114313078 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA14300244 |
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No |
| Please provide contact information of the holder of the original Donor Information Sheet. | 2696669750@qq.com |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
| How may genetic information associated with the cell line be accessed? | No information |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | The Review Board of The First Affiliated Hospital of Sun Yat-Sen University |
| Approval number | 2021001354 |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
| Source cell type |
A sample of peripheral blood mononuclear cells.
Synonyms
|
Reprogramming method |
|
| Vector type | Integrating |
| Vector | Virus (Hemagglutinating virus of Japan) |
| Is the used vector excisable? |
Unknown |
| Absence of reprogramming vector(s)? |
Unknown |
| Reprogramming vectors silenced? | |
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Medium |
mTeSR™ Plus
|
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| TRA 1-81 |
Yes |
|
|
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
Normal
Passage number: 4
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.